Conditions: Pain Diabetic Neuropathy
Keywords: Pain Diabetic Neuropathy PDN Analgesia Efficacy
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 127
Healthy volunteers: no

Brief summary:
The purpose of this study is to investigate if AZD2066 can relieve the pain arising from painful diabetic neuropathy compared to placebo.

Detailed description:

Arms:
arm 1: None arm 2: None

Interventions: intervention 1: AZD2066 intervention 2: Placebo
Intervention descriptions: intervention 1: Capsule, once daily, 12 mg AZD2066 day 1-4 and 18 mg AZD2066 day 5-28. intervention 2: Capsule, once daily

Protocol document: